Results 91 to 100 of about 2,572,587 (193)

Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus. [PDF]

J Diabetes Res, 2023
Song W, Wen J, Zhang J, Luo M, Hu Y, Zhang Y, Fan G, Zhao L.   +7 more
europepmc   +1 more source

Comparison between Continuous Subcutaneous Insulin Infusion and Multiple Daily Insulin Injections, its Effects on Quality of Life among Children with Type 1 Diabetes [PDF]

, 2014
Type 1 diabetes mellitus (T1DM) is a common chronic disease in childhood. Fifty percent of subjects with T1DM are diagnosed within the first 15 years of life. Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily insulin Injections (MDI) are
Abusaad, Fawzia Elsayed
core  

Clinical Experience of Using Telemedicine for the Management of Patients Using Continuous Subcutaneous Insulin Infusion in a Highly Complex Latin American Hospital. [PDF]

Int J Environ Res Public Health, 2023
Guzman GE, Escobar MF, Arias-Valderrama O, Guerra MA, Martínez V.   +4 more
europepmc   +1 more source

A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes. [PDF]

Medicina (Kaunas), 2023
Chatziravdeli V, Lambrou GI, Samartzi A, Kotsalas N, Vlachou E, Komninos J, Tsartsalis AN.   +6 more
europepmc   +1 more source

Continuous subcutaneous insulin infusion: a local perspective

Hong Kong Medical Journal, 2023
T T L, Yau, A J, Jenkins, R C W, Ma
openaire   +2 more sources

Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy. [PDF]

Diabetes Ther, 2023
Wang SH, Shao W, Jiang QH, Zheng XL, Shen QB, Lin XY, Zhang QQ, Zhang LL, Shi XL, Wang WG, Li XJ.   +10 more
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion [PDF]

Diabetes Care, 1993
openaire   +1 more source

Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. [PDF]

Diabetes Technol Ther, 2023
Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA, Adult and Pediatric MiniMed™ HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group.   +30 more
europepmc   +1 more source

Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective. [PDF]

Diabetol Metab Syndr, 2022
El Samahy MH, Salah NY, Abdeen MS, Falastin BRK.   +3 more
europepmc   +1 more source

Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study. [PDF]

Arch Endocrinol Metab, 2023
Ogassavara J, Dualib PM, Mattar R, Dib SA, de Almeida-Pititto B.   +4 more
europepmc   +1 more source